Studies on the mechanism of action of nerve growth factor (NGF) Among the biological actions of nerve growth factor protein (NGF) (for review, see ref. 1) is stimulation of neurite outgrowth from responsive sympathetic and dorsal root ganglionic neurons both in vivo (1) and in vitro (1-3). Early studies on RNA and protein synthesis by ganglia treated with NGF in vitro led to the suggestion that the effects of the factor on neurite outgrowth are mediated via transcription of DNA into new RNA (1, 4). More recent experiments, however, indicate that explanted sympathetic (3) or dorsal root (5) ganglia undergo at least 24 hr of NGF-stimulated neurite outgrowth in the presence of actinomycin D at levels that block nearly all cellular RNA synthesis. Such findings have suggested that NGF-stimulated neurite outgrowth does not require new RNA synthesis (3). However, several aspects of such in vitro experiments must be considered. The ganglia used in all probability have already responded to endogenous NGF in vivo. This means that the in vitro experiments may involve continuation rather than initiation of metabolic responses to NGF (3, 5) and that such experiments may test NGF-stimulated regeneration rather than generation (or initiation) of neurite outgrowth.
tion of neurites in response to NGF. Regeneration is defined here as NGF-dependent regrowth of neurites within 24 hr after subculture of NGF-treated PC12 cells. As in cultures of normal NGF-responsive neurons, neurite regeneration by PC12 cells occurs even in the presence of high concentrations of RNA synthesis inhibitors. Generation of neurites is defined as the de novo initiation of outgrowth when PC12 cells are exposed to NGF for the first time. In contrast to regeneration, neurite generation takes place with a lag of at least 24 hr and is blocked by low concentrations of RNA synthesis inhibitors. Such findings suggest that there are both RNA synthesis-dependent and -independent pathways in the mechanism whereby NGF stimulates neurite outgrowth. In addition, NGF-treated PC12 cells undergo a time-dependent loss of the capacity for neurite regeneration after pretreatment with RNA synthesis inhibitors or withdrawal of NGF. Such findings suggest that (j) initiation of neurite outgrowth requires NGF-stimulated, RNA synthesis-dependent accumulation of intracellular material(s), (ih) once such accumulation occurs, RNA synthesis-independent regeneration can occur (but only in the presence of NGF), and (iii) the turnover of such material(s) in the absence of their replacement leads to loss of the capacity for regeneration. A tentative sequence is presented for the events whereby NGF may stimulate neurite outgrowth.
Among the biological actions of nerve growth factor protein (NGF) (for review, see ref. 1) is stimulation of neurite outgrowth from responsive sympathetic and dorsal root ganglionic neurons both in vivo (1) and in vitro (1) (2) (3) . Early studies on RNA and protein synthesis by ganglia treated with NGF in vitro led to the suggestion that the effects of the factor on neurite outgrowth are mediated via transcription of DNA into new RNA (1, 4) . More recent experiments, however, indicate that explanted sympathetic (3) or dorsal root (5) ganglia undergo at least 24 hr of NGF-stimulated neurite outgrowth in the presence of actinomycin D at levels that block nearly all cellular RNA synthesis. Such findings have suggested that NGF-stimulated neurite outgrowth does not require new RNA synthesis (3). However, several aspects of such in vitro experiments must be considered. The ganglia used in all probability have already responded to endogenous NGF in vivo. This means that the in vitro experiments may involve continuation rather than initiation of metabolic responses to NGF (3, 5) and that such experiments may test NGF-stimulated regeneration rather than generation (or initiation) of neurite outgrowth.
In addition to cultures of normal neurons, pheochromocytoma cells represent another class of cells that respond to NGF in vitro (6) . A clonal line (designated PC12) of rat pheochromocytoma cells has been established (7) and characterized (7) (8) (9) (10) , and this line promises to be a useful model system for study of the mechanism of action of NGF. Such cells do not require NGF for survival and replication in serum-containing medium, but after several days in the presence of NGF they cease replication and extend long, microtubule-containing neurites (7) . One particularly unique advantage of the line is that, because PC12 cells do not require NGF for survival under normal culture conditions, non-NGF-treated cultures may be used as experimental controls. This contrasts with normal NGF-responsive neurons which require NGF for survival in vitro and which thus die in its absence (2) . A second experimental advantage of PC12 cells is that, unlike normal cells, they may be used to study the initial steps whereby NGF stimulates initiation of neurite outgrowth from cells that have never had previous exposure to detectable levels of the factor. Furthermore, PC12 cultures may also be used to study NGF-stimulated regeneration of neurites. That is, if NGF-treated PC12 cells are divested of their neurites by mechanical means, such cells begin NGF-dependent regrowth of neurites within 24 hr (11).
We report here that NGF-stimulated regeneration of neurites can occur in the presence of RNA synthesis inhibitors but generation of neurites cannot. We suggest a tentative model for the mode of action of NGF based on such findings.
MATERIALS AND METHODS
Cell Culture. PC12 cells or their noncholinergic subclone PC12-A1 (10) were maintained as described (7, 9) on collagen-coated 35-mm tissue culture dishes in the presence (50 ng/ml) or absence of 2.5S mouse salivary gland NGF (12) . Cells were plated at 0.2-1 X 106 per dish, and culture medium was changed three times weekly. Proportions of process-bearing cells were determined by strip counts as described (7, 11 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. Uptake was linear for this entire period. After labeling, the medium was removed, the cultures were rapidly washed three times with saline, and the cells were scraped off the dishes in ice-cold water. After removal of an aliquot for total counts, macromolecules were precipitated in ice-cold 5% trichloroacetic acid and collected on glss filters (GF/A; Whatman). Radioactivity was measured by liquid scintillation counting using Packard Instagel. Incorporation was calculated on the basis of total non-acid-precipitable intracellular radioactivity and was thus corrected for drug effects on uptake. At drug concentrations that suppressed neurite generation, uptake was affected by less than 15%. Three to six sister cultures were assayed for each point, and data are expressed as mean I SEM. RESULTS Neurite Regeneration. To assess the dependence of neurite regeneration on RNA synthesis, clonal PC12 pheochromocytoma cells were treated for 1-2 weeks with NGF and then dislodged from the culture dishes by repeated aspiration of medium with a pasteur pipette. As a result of dislodgment, neurites were lost from the cells both by mechanical shearing and by resorption into the cell body. After several washes with NGF-free medium, the cells were replated in the presence or absence of NGF and of RNA synthesis inhibitors. These inhibitors were: actinomycin D, an intercalating agent which blocks synthesis of rRNA and heterogeneous nuclear (hnRNA) (13) ; camptothecin, an alkaloid which inhibits synthesis of rRNA, hnRNA, and mRNA by an as yet unclear mechanism (14) ; and cordycepin (3-deoxyadenosine), a base analogue which interferes with synthesis of rRNA and formation of mRNA (15) . In the presence of NGF (see also ref. 11), 50-80% of the cells regenerated neurites by 24 hr, whereas only 2-10% did so when NGF was not added to the cultures (Table 1) . Significantly, a comparable or only slightly reduced level of NGF-dependent regeneration occurred in the presence of each of the above drugs at concentrations that produced substantial inhibition of [3H]uridine incorporation (Table 1 ; Fig. 1 ).
Neurite Initiation. In contrast to regeneration, de nowo initiation of neurite outgrowth by PC12 cells after treatment with NGF was preceded by a lag of at least 24 hr. This lag period was also present in cells whose proliferation had been blocked by treatment with arabinofuranosylcytosine or serum-free medium (16) and thus did not appear to be merely a consequence of cell cycle. After the initial lag, outgrowth of identifiable neurites (i.e., processes at least 20 Im in length) commenced so that the proportion of fiber-bearing cells in NGF-treated cultures increased progressively to about 90% within 1 week (Fig. 2) . Fig. 2 also shows the effects of various concentrations of the RNA synthesis inhibitors on NGF-induced initiation of neurite outgrowth in PC12 cultures. Initiation of outgrowth was significantly blocked in the presence of each of these drugs at concentrations 0.1-10% of those at which neurite regeneration took place. Moreover, neurite generation could also be inhibited in cultures that had already been treated with NGF for short periods of time. For example, when cultures were exposed to NGF alone for 24 hr and then to NGF and inhibitor for the next 24 hr, initiation of outgrowth was also blocked (Fig. 1 ). Fig. 3 figure) and were scored at various times thereafter for proportion of process-bearing cells. (A) Actinomycin D; (B) camptothecin; (C) cordycepin. cells excluded trypan blue and morphologically were similar to NGF-untreated controls. Further evidence for cell viability and vitality was gained in the case of camptothecin. One advantage of this drug is that its effects on RNA synthesis are completely and rapidly reversible (14) . The experiment shown in Fig. 4 illustrates the effects of withdrawing camptothecin from PC12 cultures after various times of pretreatment with both the drug and NGF. At each time, removal of camptothecin was followed by commencement of neurite outgrowth. Significantly,-the lag period normally observed prior to initiation of neurite outgrowth was not present, and 20-40% of the cells had generated neurites within 24 hr after drug withdrawal. Comparison of the curves for rate of initiation of neurite outgrowth after addition of NGF alone or removal of camptothecin shows that the latter is about 18 hr more rapid than the former. These results suggest that at least part of the sequence of events whereby NGF initiates neurite outgrowth may be carried out in presence of concentrations of camptothecin that suppress neurite outgrowth. Loss of "NGF-Priming" One interpretation of the presently observed differences in time course and drug sensitivities of neurite generation and regeneration is that NGF treatment causes a time-and RNA synthesis-dependent alteration in cell composition that is required for neurite outgrowth. In NGFtreated (or "NGF-primed") cells, such changes would already be present and, upon blockade of RNA synthesis, might persist for a sufficient length of time to sustain neurite regeneration. Results of several experiments are consistent with this model. Table 2 shows the results of an experiment in which fiberbearing NGF-primed PC12 cultures were treated with a low dose of camptothecin for 1 day before being subcultured for regeneration. Although the camptothecin-treated cells did not show altered morphology, in contrast to untreated controls they no longer showed the capacity for RNA synthesis-independent neurite regeneration.
In a second type of experiment, fiber-bearing NGF-primed cells were subcultured for regeneration but in the absence of NGF. After various times, NGF was added to the cultures and the cells were scored 1 day later for neurite regeneration. In the absence of NGF, the cells showed a time-dependent loss of the capacity for neurite regeneration (Fig. 5) (Table 2) with RNA synthesis inhibitors would thus be due to the turnover and nonreplacement of such material(s).
If the action of NGF requires newly synthesized species of RNA, then the question arises as to the role of such RNA in stimulating neurite outgrowth. One possibility is that the RNA itself plays a structural role in organization and assembly of neurites. There is recent evidence, for example, that RNA in centrioles may play a functional role in nucleating assembly of microtubules (24) . A second possibility is that such RNA plays a role in the synthesis of differentiation-associated proteins. In this regard, experiments involving electrophoretic resolution of peptides from NGF-treated and untreated PC12 cells indicate that NGF does not bring about major changes in the overall pattern of PC12 cell proteins but that it does result in a relatively small number of quantitative alterations in protein synthesis (25) . Two of these NGF-dependent changes in particular are selectively blocked by low levels of camptothecin (ref. 25 ; J. C. McGuire and L. A. Greene, unpublished data).
On this basis, and in consideration of the above discussion and experimental evidence, one tentative model for the types of events that comprise the mode of action of NGF in initiating neurite outgrowth is as follows. (i) NGF interacts with one or more types of surface receptors. This leads to subsequent events: (ii) As suggested by the rapid initiation of neurite outgrowth that occurs when camptothecin is withdrawn from NGFtreated cultures, there occurs one or more required events that are not blocked by levels of this drug that suppress neurite outgrowth. (iii) NGF treatment leads to stimulated synthesis of selective species of RNA. (iv) At least one consequence of the change(s) in RNA synthesis is a minor but required change in the pattern of protein synthesis. (v) As indicated by the findings that neurite regeneration requires NGF but is not blocked by high concentrations of RNA synthesis inhibitors, NGF also triggers required events that are independent of new RNA synthesis. This could include the events described in if above.
(vi) Neurite outgrowth occurs for the most part via assembly or rearrangement of types of structural proteins already present prior to NGF treatment and whose relative rates of synthesis are little, if at all, affected by NGF. Further experiments-with normal responsive neurons and with the PC12 line should provide means for more extensive testing and refining of this and other models for the mechanism of NGF-stimulated neurite outgrowth.
